TrimGen

TrimGen is a biotechnology company specializing in the development and manufacture of molecular diagnostic products for oncology and personalized medicine. The company's core technology, Shifted-Termination PCR (ST-PCR), enables highly sensitive detection of somatic mutations in clinical samples, including those with low tumor content. TrimGen provides a range of mutation analysis kits for critical biomarkers such as KRAS, BRAF, and EGFR, which are essential for guiding targeted therapy decisions in cancers like colorectal and lung cancer. In addition to oncology, the company offers solutions for infectious disease testing and genetic research. TrimGen is headquartered in Maryland and serves clinical laboratories and research institutions worldwide.